US3473524A - Syringe ampoules - Google Patents

Syringe ampoules Download PDF

Info

Publication number
US3473524A
US3473524A US610898A US3473524DA US3473524A US 3473524 A US3473524 A US 3473524A US 610898 A US610898 A US 610898A US 3473524D A US3473524D A US 3473524DA US 3473524 A US3473524 A US 3473524A
Authority
US
United States
Prior art keywords
wall
ampoule
apex angle
invertible
collapsible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US610898A
Inventor
John Drewe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BRITAMPOULA AG
Original Assignee
BRITAMPOULA AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BRITAMPOULA AG filed Critical BRITAMPOULA AG
Application granted granted Critical
Publication of US3473524A publication Critical patent/US3473524A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/28Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
    • A61M5/281Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle using emptying means to expel or eject media, e.g. pistons, deformation of the ampoule, or telescoping of the ampoule
    • A61M5/282Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle using emptying means to expel or eject media, e.g. pistons, deformation of the ampoule, or telescoping of the ampoule by compression of deformable ampoule or carpule wall
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M3/00Medical syringes, e.g. enemata; Irrigators

Definitions

  • This invention relates to ampoules which are provided, or are adapted to be provided, at one end with a hypodermic needle so as to form a surgical hypodermic syringe or a device for taking and storing specimens of blood or other body fluids.
  • an ampoule comprising a collapsible chamber having two coaxially aligned, opposed, frusto-conical walls united at their base ends, one of which walls is resiliently deformable, when a predetermined axial compression force is applied to said chamber, from its normal expanded position, past a dead-centre position, into an inverted collapsed position, in which it lies close against the inner surface of the other wall, where it will be biased to remain until an axial tension force is applied to the chamber to return the said one wall past the dead-centre position to its expanded position.
  • ampoule of the character referred to will be used hereafter and is used in this specification to mean an ampoule constructed and arranged to operate in the manner hereinbefore described.
  • An ampoule of the character referred to may be made of a transparent or translucent material and fitted at one end with a hollow needle so as to form a device taking samples of body fluids or a hypodermic syringe.
  • the collapsible chamber thereof may be the only collapsible portion which, when expanded, is capable of containing a gas or liquid, whereas, when such an ampoule is to be used as part of a hypodermic syringe, its collapsible chamber preferably constitutes one section, or some but not all sections of a concertina-type collapsible bellows, as in the case of the ampoule forming the subject of the aforementioned US. Patent 3,340,869.
  • the procedure for carrying out this aspiration test with a syringe comprising an ampoule is as follows.
  • the syringe which has been prefilled with a predetermined quantity of a liquid drug is held preferably with the needle uppermost, and the independently collapsible bellows sections (or each such section if there is more than one) is collapsed, thereby expelling all air and surplus liquid from the ampoule, while leaving the remaining bellows sections filled with the liquid drug.
  • the neede is then inserted into the patient, after which the independently collapsible bellows section (or each of such sections) is pulled out so that it returns to a partially expanded position.
  • the invertible frusto-conical wall of the collapsible chamber of the ampoule has an apex angle of between and while the other frusto-conical wall of the said chamber is not only stiffer (i.e. more resistant to deformation by an axial compression force applied to the ends of the container portion) than the invertible wall, but also has an apex angle which is not appreciably smaller and not more than 5 larger, than the apex angle of the invertible wall.
  • the apex angle of the said other wall is from 3.5 to 4.5 larger than that of the invertible wall.
  • the lower limit of 90 for the apex angle of the invertible wall and the limit of 5 for the extent to which the apex angle of the said other wall may exceed that of the invertible wall are imposed by practical considera tions.
  • the apex angle of the invertible wall is made substantially less than 90, excessive force will have to be applied in order to deform this wall to its dead-centre position; also, if the apex angle of this wall is more than about 5 smaller than the apex angle of the other wall, then the invertible wall will not lie closely against the inner surface of the other wall.
  • the said other wall if its apex angle were to be more than 5 greater than that of the invertible wall,
  • the location of the dead-centre position of the invertible wall is also affected by other factors, including, the external diameter of the collapsible chamber, the material of which this chamber is made and the thickness of the invertible wall.
  • Suitable materials include nylon polymers, polyethylene, polypropylene and surgical grades of polyvinyl chloride and the wall-thickness of the invertible wall will be so chosen, having regard to the nature of the material of which it is composed, the diameter of the bellows section and its apex angle, that the force required to deform this wall as far as the dead-centre point will not be greater than that which can be applied manually without undue effort.
  • the collapsible chamber is closed at the smaller diameter end of the invertible frusto-conical wall by means of a substantially flat, circular platform which is thicker than the said invertible wall, but not so thick as to be incapable of undergoing substantial resilient deformation during collapse of the latter after the dead-centre point has been passed, and which has a diameter such that it will not interfere with the other wall as it moves into the fully collapsed position.
  • the platform preferably has a centrally located, externally projecting operating stud formed integrally with it and the arrangement is advantageously such that, when the stud is pressed in, the platform will remain almost flat until the invertible wall has been collapsed beyond the dead-centre-point, whereupon it will progressively be deformed into a shape between that of a segment of a sphere and that of a cone.
  • FIGURE 1 is a partly sectioned side elevation of a surgical hypodermic syringe embodying an ampoule which is shown in the fully expanded position and FIGURE 2 is a fragmentary view of the ampoule with a section thereof collapsed.
  • the syringe has a bellows-type ampoule which comprises two zbellows sections 11 for containing a predetermined quantity of a liquid drug and a third bellows section 12 which is independently collapsible and expandable for carrying out what is commonly known as the aspiration test.
  • a nozzle 13 projects coaxially from the end of the ampoule which is remote from the bellows section 12 and is fitted with a hypodermic needle 14 which has a removable cover 15 applied over it.
  • At the other end of the ampoule is closed by a platform 16, the centre portion of which carries a stud having a head 17 and a neck 18.
  • the independently collapsible bellows section 12 is collapsible by applying to the stud 17, 18 an axial force which is smaller than that required to collapse the bellows sections 11 and furthermore it is so constructed and arranged that it collapses with an over-dead-centre action, i.e. an axial force applied to the head 17 of the stud in the direction towards the needle 14 displaces the platform 16 and the adjoining wall 21 to a position just beyond a dead-centre position (not shown), after which the wall 21 will continue to move in the same direction under the action of its own inherent resilience until it reaches the fully collapsed position shown in FIGURE 2.
  • an over-dead-centre action i.e. an axial force applied to the head 17 of the stud in the direction towards the needle 14 displaces the platform 16 and the adjoining wall 21 to a position just beyond a dead-centre position (not shown), after which the wall 21 will continue to move in the same direction under the action of its own inherent resilience until it reaches the fully collapsed
  • FIGURES 1 and 2 Those features of construction and operation of the hypodermic syringe illustrated in FIGURES 1 and 2 which have been described so far are, in general, the same as corresponding features of the syrings described in and illustrated by FIGURES 1 and 2 of the specification of US. Patent 3,340,869.
  • the present syringe incorporates certain improvements which will now be described.
  • the apex angle 04 of the frusto-conical wall 21 is 96 while the apex angle 6 of the wall 22 is 4 larger, i.e. 100. Due to the relatively small size of its apex angle a of the wall 21, a corresponding high axial force must be applied against the head 17 of the stud in order to effect inversion of the wall 21 from the expanded position shown in FIGURE 1 into the collapsed position shown in FIGURE 2. As has previously been made clear the wall 22 must remain substantially undeformed during inversion of the wall 21 and in order to compensate for the reduction in stiffness which results from its larger apex angle 5, this wall 22 is made substantially thicker than the wall 21.
  • FIG. 16 is made substantially thicker than the wall 21, but not so thick as to prevent it from undergoing resilient deformation from the flat shape which it has when the wall 21 is in its expanded position (FIG. 1) to inwardly curved shape which it has when the wall 21 is in its collapsed position (FIGURE 2).
  • the diameter of the platform 16 when fiat is somewhat less than that of the constricted opening between the wall 22 and its junction with the adjoining wall 23 of the nearer bellows element 11.
  • the neck 18 of the stud is made of as small diameter as possible without rendering it liable to bend when axial pressure is applied to the head for the purpose of collapsing the wall 21. Since the neck 18 and the platform 16 are moulded integrally with each other, the angle between them is rounded as shown at 24. The radius of the rounded surface 24 is, however, as small as possible in order to avoid undue interference with the flexing of the platform 16 during the last part of its movement into the fully collapsed position.
  • the platform 16 When force is applied to the head 17 of the stud to collapse the bellows element 12, the platform 16 will remain almost flat until the dead-centre-position is reached and will thereafter be progressively deformed until, when the element 12 is fully collapsed, it assumes the shape shown in FIGURE 2 which is something between a segment of a hollow cone and a segment of a hollow sphere.
  • the present invention is not only applicable to ampoules for hypodermic syringes, as described above with reference to the drawings, but also to blood-sampling devices in which case there is no need to provide bellows sections corresponding to those shown at 11 in FIGURE 1 of the accompanying drawings.
  • a syringe ampoule comprising:
  • the other of said walls being stiffer than said one wall and having an apex angle which is not substantially smaller and not more than 5 larger than the apex angle of the said one wall, and
  • a mounting for a hypodermic needle provided on one end of said collapsible chamber and having a delivery and suction duct extending through it and communicating with the interior of said chamber.
  • a syringe ampoule according to claim 1 wherein the apex angle of the said other wall is from 3.5 to 45 larger than that of the said one wall.
  • a syringe ampoule according to claim 1 comprising in addition:
  • said platform being thicker than the said one wall and having a diameter such that it remains out of contact with the inner surface of the said one wall when the collapsible chamber is collapsed
  • a nozzle constituting the said needle mounting and projecting axially from the smaller diameter end of said other Wall.
  • An ampoule comprising a collapsible chamber having two coaxially aligned, opposed, frusto-conical walls united at their base ends, one of which walls is resiliently deformable, when a predetermined axial compression force is applied to said chamber, from its normal expanded position, past a dead-centre-posltion, into an inverted collapsed position, in which it lies close against the inner surface of the other wall, where it will be biased to remain until an axial tension force is applied to the chamber to return the said one wall past the dead-centreposition to its expanded position, wherein the invertible frusto-conical wall of the collapsible chamber has an apex angle of between and while the other frusto-conical wall of the said chamber is not only stiffer than the invertible wall, but also has an apex angle which is not appreciably smaller and not more than 5 larger, than the apex angle of the invertible wall.

Landscapes

  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Description

Oct. 21, 1969 J. DREWE 3,473,524
' SYRINGE AMPOULES Filed Jan. 23, 1967 i5 i4 l3 16 M 3 18 ited States Patent 3,473,524 SYRINGE AMPOULES John Drewe, Buntingford, England, assignor to Britampoula A.G., Chur, Switzerland Filed Jan. 23, 1967, Ser. No. 610,898 Claims priority, application Great Britain, Feb. 8, 1966, 5,55 4/ 6 6 Int. Cl. A611) /10; A61m 27/00 US. Cl. 128-2 5 Claims ABSTRACT OF THE DISCLOSURE CROSS-REFERENCES TO RELATED APPLICATIONS Reference is directed to copending patent application Ser. No. 383,777 filed on July 20, 1964 in the name of Arthur Bane, now US. Patent 3,340,869.
This invention relates to ampoules which are provided, or are adapted to be provided, at one end with a hypodermic needle so as to form a surgical hypodermic syringe or a device for taking and storing specimens of blood or other body fluids.
More specifically the invention is concerned with an ampoule comprising a collapsible chamber having two coaxially aligned, opposed, frusto-conical walls united at their base ends, one of which walls is resiliently deformable, when a predetermined axial compression force is applied to said chamber, from its normal expanded position, past a dead-centre position, into an inverted collapsed position, in which it lies close against the inner surface of the other wall, where it will be biased to remain until an axial tension force is applied to the chamber to return the said one wall past the dead-centre position to its expanded position. The inherent resilience of the said one wall of such an ampoule will act in opposition to the applied axial compression or tension force until the dead-centre position is reached, after which the direction in which the said inherent resilience acts will be reversed so that the said one wall will be biased to complete its movement into the collapsed or expanded position respectively.
The expression ampoule of the character referred to will be used hereafter and is used in this specification to mean an ampoule constructed and arranged to operate in the manner hereinbefore described.
An ampoule of the character referred to may be made of a transparent or translucent material and fitted at one end with a hollow needle so as to form a device taking samples of body fluids or a hypodermic syringe. When such an ampoule is to be used as part of a device for taking samples of body fluids, the collapsible chamber thereof may be the only collapsible portion which, when expanded, is capable of containing a gas or liquid, whereas, when such an ampoule is to be used as part of a hypodermic syringe, its collapsible chamber preferably constitutes one section, or some but not all sections of a concertina-type collapsible bellows, as in the case of the ampoule forming the subject of the aforementioned US. Patent 3,340,869.
An important advantage of which is achieved by using the ampoule according to my said copending patent application is that it enables the so-called aspiration test to be carried out reliably and safely.
The procedure for carrying out this aspiration test with a syringe comprising an ampoule according to said copending patent application is as follows. The syringe which has been prefilled with a predetermined quantity of a liquid drug is held preferably with the needle uppermost, and the independently collapsible bellows sections (or each such section if there is more than one) is collapsed, thereby expelling all air and surplus liquid from the ampoule, while leaving the remaining bellows sections filled with the liquid drug. The neede is then inserted into the patient, after which the independently collapsible bellows section (or each of such sections) is pulled out so that it returns to a partially expanded position. As a result of the return movement of the independently collapsible bellows section or sections, suction will be applied at the needle point. If blood is drawn into the ampoule, the user will know that the needle has penetrated a blood vessel. In cases where intravenous injection is required, the liquid drug can now be injected by collapsing the remaining bellows element or elements. Otherwise, e.g. in cases where intramuscular injection is required, the needle must be withdrawn and the test repeated at one or more different injection sites until no blood is drawn in as a result of the pulling out of the independently collapsible bellows section (or sections) to its (or their) partially expanded position.
It is of course important to ensure that the independently collapsible section or sections will remain in the fully collapsed condition while the needle is being inserted for purposes of the aspiration test. If, however, the deadcentre position of the or each independently collapsible section is close to its fully collapsed position, any distortion of the ampoule as a whole during insertion of the needle is liable to cause the or each independently collapsible element to return prematurely to its expanded position.
It is accordingly an object of this invention to provide an improved ampoule of the character referred to in which the dead-centre position is located sufliciently far from the fully collapsed position to avoid any appreciable risk of accidental or premature return of the independently collapsible element or elements to the fully expanded position.
With this object in view the invertible frusto-conical wall of the collapsible chamber of the ampoule according to this invention has an apex angle of between and while the other frusto-conical wall of the said chamber is not only stiffer (i.e. more resistant to deformation by an axial compression force applied to the ends of the container portion) than the invertible wall, but also has an apex angle which is not appreciably smaller and not more than 5 larger, than the apex angle of the invertible wall. Preferably, the apex angle of the said other wall is from 3.5 to 4.5 larger than that of the invertible wall.
The lower limit of 90 for the apex angle of the invertible wall and the limit of 5 for the extent to which the apex angle of the said other wall may exceed that of the invertible wall are imposed by practical considera tions. For example, if the apex angle of the invertible wall is made substantially less than 90, excessive force will have to be applied in order to deform this wall to its dead-centre position; also, if the apex angle of this wall is more than about 5 smaller than the apex angle of the other wall, then the invertible wall will not lie closely against the inner surface of the other wall. Furthermore, the said other wall, if its apex angle were to be more than 5 greater than that of the invertible wall,
would need to be made of substantial wall thickness or to be reinforced by substantial stifiening ribs in order to ensure that it is stiffer than the invertible wall.
It will of course be appreciated that the location of the dead-centre position of the invertible wall is also affected by other factors, including, the external diameter of the collapsible chamber, the material of which this chamber is made and the thickness of the invertible wall. Suitable materials include nylon polymers, polyethylene, polypropylene and surgical grades of polyvinyl chloride and the wall-thickness of the invertible wall will be so chosen, having regard to the nature of the material of which it is composed, the diameter of the bellows section and its apex angle, that the force required to deform this wall as far as the dead-centre point will not be greater than that which can be applied manually without undue effort. In the case of a syringe ampoule designed for administering a 1 cc. dose and made from a certain grade of polyethylene, it was found that a range of wall thickness from 0.005 to 0.02 inch was suitable when the bellows diameter was in the range of 0.6 to 0.8 inch.
According to a further feature of this invention, the collapsible chamber is closed at the smaller diameter end of the invertible frusto-conical wall by means of a substantially flat, circular platform which is thicker than the said invertible wall, but not so thick as to be incapable of undergoing substantial resilient deformation during collapse of the latter after the dead-centre point has been passed, and which has a diameter such that it will not interfere with the other wall as it moves into the fully collapsed position. The platform preferably has a centrally located, externally projecting operating stud formed integrally with it and the arrangement is advantageously such that, when the stud is pressed in, the platform will remain almost flat until the invertible wall has been collapsed beyond the dead-centre-point, whereupon it will progressively be deformed into a shape between that of a segment of a sphere and that of a cone.
A preferred embodiment of this invention will now be described by way of example with reference to the accompanying drawings:
FIGURE 1 is a partly sectioned side elevation of a surgical hypodermic syringe embodying an ampoule which is shown in the fully expanded position and FIGURE 2 is a fragmentary view of the ampoule with a section thereof collapsed.
The syringe has a bellows-type ampoule which comprises two zbellows sections 11 for containing a predetermined quantity of a liquid drug and a third bellows section 12 which is independently collapsible and expandable for carrying out what is commonly known as the aspiration test. A nozzle 13 projects coaxially from the end of the ampoule which is remote from the bellows section 12 and is fitted with a hypodermic needle 14 which has a removable cover 15 applied over it. At the other end of the ampoule is closed by a platform 16, the centre portion of which carries a stud having a head 17 and a neck 18.
The independently collapsible bellows section 12 is collapsible by applying to the stud 17, 18 an axial force which is smaller than that required to collapse the bellows sections 11 and furthermore it is so constructed and arranged that it collapses with an over-dead-centre action, i.e. an axial force applied to the head 17 of the stud in the direction towards the needle 14 displaces the platform 16 and the adjoining wall 21 to a position just beyond a dead-centre position (not shown), after which the wall 21 will continue to move in the same direction under the action of its own inherent resilience until it reaches the fully collapsed position shown in FIGURE 2.
To restore the bellows section 12 to the fully expanded position shown in FIGURE 1, the user pulls the stud 17, 18 in the direction away from the needle 1 until the platform 16 and wall 21 pass the dead-centreposition in the reverse direction, whereupon the expansion of the bellows section 12 will be completed by the continued movement of the wall 21 under the action of its own resilience.
Those features of construction and operation of the hypodermic syringe illustrated in FIGURES 1 and 2 which have been described so far are, in general, the same as corresponding features of the syrings described in and illustrated by FIGURES 1 and 2 of the specification of US. Patent 3,340,869. The present syringe, however, incorporates certain improvements which will now be described.
Referring to FIGURE 1, the apex angle 04 of the frusto-conical wall 21 is 96 while the apex angle 6 of the wall 22 is 4 larger, i.e. 100. Due to the relatively small size of its apex angle a of the wall 21, a corresponding high axial force must be applied against the head 17 of the stud in order to effect inversion of the wall 21 from the expanded position shown in FIGURE 1 into the collapsed position shown in FIGURE 2. As has previously been made clear the wall 22 must remain substantially undeformed during inversion of the wall 21 and in order to compensate for the reduction in stiffness which results from its larger apex angle 5, this wall 22 is made substantially thicker than the wall 21. It has been found that both the choice of 96 for the apex angle a of the wall 21 instead of a larger angle such as for example and the fact that the apex angle of the wall 22 p is 4 larger than the apex angle or have the effect of increasing the distance between the dead centre position of the wall 21 and its fully collapsed position and hence ensuring a more reliable over-dead-centre action and more positive retention of the wall 21 in its fully collapsed position.
Further improvements in the reliability of the overdead-centre action and in the stability of the wall 21 when in the fully collapsed position shown in FIGURE 2 are obtained by the construction and arrangement of the platform 16. This platform 16 is made substantially thicker than the wall 21, but not so thick as to prevent it from undergoing resilient deformation from the flat shape which it has when the wall 21 is in its expanded position (FIG. 1) to inwardly curved shape which it has when the wall 21 is in its collapsed position (FIGURE 2). The diameter of the platform 16 when fiat is somewhat less than that of the constricted opening between the wall 22 and its junction with the adjoining wall 23 of the nearer bellows element 11. The neck 18 of the stud is made of as small diameter as possible without rendering it liable to bend when axial pressure is applied to the head for the purpose of collapsing the wall 21. Since the neck 18 and the platform 16 are moulded integrally with each other, the angle between them is rounded as shown at 24. The radius of the rounded surface 24 is, however, as small as possible in order to avoid undue interference with the flexing of the platform 16 during the last part of its movement into the fully collapsed position.
When force is applied to the head 17 of the stud to collapse the bellows element 12, the platform 16 will remain almost flat until the dead-centre-position is reached and will thereafter be progressively deformed until, when the element 12 is fully collapsed, it assumes the shape shown in FIGURE 2 which is something between a segment of a hollow cone and a segment of a hollow sphere.
The present invention is not only applicable to ampoules for hypodermic syringes, as described above with reference to the drawings, but also to blood-sampling devices in which case there is no need to provide bellows sections corresponding to those shown at 11 in FIGURE 1 of the accompanying drawings.
I claim:
1. A syringe ampoule, comprising:
a collapsible chamber having two coaxially aligned,
opposed, frusto-conical walls united at their base ends, one of said walls being resiliently deformable under a predetermined axial compression force from an expanded position into an inverted collapsed position in which it lies close against the inner surface of the other wall and having an apex angle of between 90 and 100, and
the other of said walls being stiffer than said one wall and having an apex angle which is not substantially smaller and not more than 5 larger than the apex angle of the said one wall, and
a mounting for a hypodermic needle provided on one end of said collapsible chamber and having a delivery and suction duct extending through it and communicating with the interior of said chamber.
2. A syringe ampoule according to claim 1, wherein the apex angle of the said other wall is from 3.5 to 45 larger than that of the said one wall.
3. A syringe ampoule according to claim 1, comprising in addition:
a substantially flat circular platform disposed with its main surfaces at right angles to the central axis of the collapsible container and closing said collapsible chamber at the smaller end of the said one wall,
said platform being thicker than the said one wall and having a diameter such that it remains out of contact with the inner surface of the said one wall when the collapsible chamber is collapsed,
an externally projecting operating stud formed integrally with and located centrally with respect to said platform, and
a nozzle constituting the said needle mounting and projecting axially from the smaller diameter end of said other Wall.
4. An ampoule comprising a collapsible chamber having two coaxially aligned, opposed, frusto-conical walls united at their base ends, one of which walls is resiliently deformable, when a predetermined axial compression force is applied to said chamber, from its normal expanded position, past a dead-centre-posltion, into an inverted collapsed position, in which it lies close against the inner surface of the other wall, where it will be biased to remain until an axial tension force is applied to the chamber to return the said one wall past the dead-centreposition to its expanded position, wherein the invertible frusto-conical wall of the collapsible chamber has an apex angle of between and while the other frusto-conical wall of the said chamber is not only stiffer than the invertible wall, but also has an apex angle which is not appreciably smaller and not more than 5 larger, than the apex angle of the invertible wall.
5. An ampoule according to claim 4 and comprising the addition: a substantially flat circular platform formed integrally with and extending transversely across the smaller diameter end of the said invertible frusto-conical wall, said platform being thicker than said invertible wall, and a centrally located externally projecting operating stud formed integrally with said platform, the arrangement being such that, when the stud is pressed in, the platform will remain substantially flat until the invertible wall has been collapsed beyond the dead-centreposition, whereupon it will be progressively deformed into a shape between that of a segment of a sphere and that of a cone.
References Cited UNITED STATES PATENTS 900,182. 10/1908 Mayers 128-232 X 2,673,561 3/1954 Peterson 128216 2,717,598 9/1955 Krasno 128-216 2,911,972 11/1959 Elinger 128-216 3,340,869 9/1967 Bane 1282 3,390,821 7/1968 Mullan 222-215 X RICHARD A. GAUDET, Primary Examiner MARTIN F. MAJESTIC, Assistant Examiner U.S. Cl. X.R. 128-216; 222-215
US610898A 1966-02-08 1967-01-23 Syringe ampoules Expired - Lifetime US3473524A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5554/66A GB1175184A (en) 1966-02-08 1966-02-08 Improvements in Syringe Ampoules.

Publications (1)

Publication Number Publication Date
US3473524A true US3473524A (en) 1969-10-21

Family

ID=9798317

Family Applications (1)

Application Number Title Priority Date Filing Date
US610898A Expired - Lifetime US3473524A (en) 1966-02-08 1967-01-23 Syringe ampoules

Country Status (4)

Country Link
US (1) US3473524A (en)
DE (1) DE1566635A1 (en)
FR (1) FR1513706A (en)
GB (1) GB1175184A (en)

Cited By (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3712295A (en) * 1970-08-03 1973-01-23 W Kline Centrifuge tube
US3991757A (en) * 1974-06-17 1976-11-16 Koninklijke Emballage Industrie Van Leer B.V. Hypodermic syringe
US4072249A (en) * 1975-03-03 1978-02-07 Landstingens Inkopscentral Container suitable for smaller quantities of fluid or semi-fluid substances
US4187960A (en) * 1978-07-27 1980-02-12 The Kendall Company Dispenser with cap and protective member
US4822332A (en) * 1988-03-31 1989-04-18 Tambrands Inc. Device for delivering an object to a cavity
US4873100A (en) * 1987-04-15 1989-10-10 The Procter & Gamble Company Bistable expandable bottle
US5308322A (en) * 1993-04-19 1994-05-03 Tennican Patrick O Central venous catheter access system
US5309924A (en) * 1992-04-29 1994-05-10 Peabody Alan M Spill-proof blood collection device
US5462208A (en) * 1994-08-01 1995-10-31 The Procter & Gamble Company Two-phase dispensing systems utilizing bellows pumps
US5509906A (en) * 1995-05-02 1996-04-23 Healthstar Pharmaceutical Services, Inc. Plungerless syringe
US5638995A (en) * 1994-10-11 1997-06-17 Mazda; Masayosi Bellows container
USD417000S (en) * 1998-05-07 1999-11-23 Vital Signs Inc. Compressible syringe
USD419672S (en) * 1998-05-08 2000-01-25 Vital Signs Inc. Plungerless syringe
US6332876B1 (en) * 1997-09-08 2001-12-25 Richard Q. Poynter Compressible syringe
US6540106B2 (en) * 2001-05-21 2003-04-01 Norman G. Gerstner Finger attachable spray device
GB2461886A (en) * 2008-07-16 2010-01-20 Donald Charles Davey A palm held hypodermic device
US20110046559A1 (en) * 2009-08-21 2011-02-24 Becton Dickinson France S.A.S. Syringe Assembly Having a Flexible or Slidable Flange
US20110094909A1 (en) * 2009-10-26 2011-04-28 Asp Plastics Pty Limited Sharps container
WO2015153469A1 (en) 2014-03-31 2015-10-08 Amcor Limited Controlled release container
US9180252B2 (en) 2012-04-20 2015-11-10 Bayer Medical Care Inc. Bellows syringe fluid delivery system
CN105979923A (en) * 2014-02-12 2016-09-28 赛诺菲-安万特德国有限公司 Reservoir for liquid medicament
US9498570B2 (en) 2010-10-25 2016-11-22 Bayer Healthcare Llc Bladder syringe fluid delivery system
US20170197031A1 (en) * 2014-06-04 2017-07-13 Merck Sharp & Dohme Corp. Prefilled disposable injection device
US10046106B2 (en) 2010-10-25 2018-08-14 Bayer Healthcare Llc Bladder syringe fluid delivery system
US10583256B2 (en) 2014-04-25 2020-03-10 Bayer Healthcare Llc Syringe with rolling diaphragm
USD879952S1 (en) * 2017-08-10 2020-03-31 Ethicon Llc Powder delivery device
US10933190B2 (en) 2015-04-24 2021-03-02 Bayer Healthcare Llc Syringe with rolling diaphragm
US11123499B2 (en) 2016-01-19 2021-09-21 Merck Sharp & Dohme Corp. Prefilled disposable injection device
US11154665B2 (en) 2015-06-24 2021-10-26 Ethicon, Inc. Hemostatic powder delivery devices and methods
US11207462B2 (en) 2016-10-17 2021-12-28 Bayer Healthcare Llc Fluid injector with syringe engagement mechanism
US11389585B2 (en) 2016-09-16 2022-07-19 Bayer Healthcare Llc Pressure jacket having syringe retaining element
US11547793B2 (en) 2016-10-17 2023-01-10 Bayer Healthcare Llc Fluid injector with syringe engagement mechanism
US11826541B2 (en) 2017-09-13 2023-11-28 Bayer Healthcare Llc Sliding syringe cap for separate filling and delivery
US11839751B2 (en) 2020-06-18 2023-12-12 Bayer Healthcare Llc In-line air bubble suspension apparatus for angiography injector fluid paths
US11918775B2 (en) 2019-09-10 2024-03-05 Bayer Healthcare Llc Pressure jackets and syringe retention features for angiography fluid injectors
US11938093B2 (en) 2020-02-21 2024-03-26 Bayer Healthcare Llc Fluid path connectors for medical fluid delivery

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2551991A1 (en) * 1974-11-19 1976-07-29 Wolfgang Dr Med Wagner Medication metering distributor for hypodermic - has dosing unit on flexible wall transmitting power pulses
US4018222A (en) * 1975-02-10 1977-04-19 Merck & Co., Inc. Syringe containing frozen vaccine
DE3420865C1 (en) * 1984-06-05 1985-08-29 B. Braun Melsungen Ag, 3508 Melsungen Infusion syringe pump
DE8430452U1 (en) * 1984-10-17 1985-05-15 Salzmann, Rudolf, 2050 Hamburg Device for withdrawing the liquid from opened glass and kink ampoules
GB2181055A (en) * 1984-11-20 1987-04-15 David John Colgate Disposable syringe
WO1987001944A1 (en) * 1985-10-01 1987-04-09 Axipac Limited Disposable syringe
US5609580A (en) * 1994-09-16 1997-03-11 Vital Signs, Inc. Injection holder for a plungerless syringe and combination plungerless syringe and injection holder

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US900182A (en) * 1906-10-23 1908-10-06 Karl L Mayers Syringe.
US2673561A (en) * 1951-03-22 1954-03-30 Jr Charles B Peterson Disposable double-action syringe
US2717598A (en) * 1952-11-21 1955-09-13 Louis R Krasno Hypodermic syringe
US2911972A (en) * 1954-09-14 1959-11-10 Elinger Adolfo Scholcoff Hypodermic syringe-ampulla
US3340869A (en) * 1963-08-08 1967-09-12 Bane Arthur Collapsible ampoules
US3390821A (en) * 1966-09-28 1968-07-02 Mullan Joseph Collapsible container

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US900182A (en) * 1906-10-23 1908-10-06 Karl L Mayers Syringe.
US2673561A (en) * 1951-03-22 1954-03-30 Jr Charles B Peterson Disposable double-action syringe
US2717598A (en) * 1952-11-21 1955-09-13 Louis R Krasno Hypodermic syringe
US2911972A (en) * 1954-09-14 1959-11-10 Elinger Adolfo Scholcoff Hypodermic syringe-ampulla
US3340869A (en) * 1963-08-08 1967-09-12 Bane Arthur Collapsible ampoules
US3390821A (en) * 1966-09-28 1968-07-02 Mullan Joseph Collapsible container

Cited By (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3712295A (en) * 1970-08-03 1973-01-23 W Kline Centrifuge tube
US3991757A (en) * 1974-06-17 1976-11-16 Koninklijke Emballage Industrie Van Leer B.V. Hypodermic syringe
US4072249A (en) * 1975-03-03 1978-02-07 Landstingens Inkopscentral Container suitable for smaller quantities of fluid or semi-fluid substances
US4282986A (en) * 1975-03-03 1981-08-11 Landstingens Inkopscentral Method for discharge of quantities of fluid or semi-fluid substances from a container
US4187960A (en) * 1978-07-27 1980-02-12 The Kendall Company Dispenser with cap and protective member
US4873100A (en) * 1987-04-15 1989-10-10 The Procter & Gamble Company Bistable expandable bottle
US4822332A (en) * 1988-03-31 1989-04-18 Tambrands Inc. Device for delivering an object to a cavity
US5309924A (en) * 1992-04-29 1994-05-10 Peabody Alan M Spill-proof blood collection device
US5308322A (en) * 1993-04-19 1994-05-03 Tennican Patrick O Central venous catheter access system
US5462208A (en) * 1994-08-01 1995-10-31 The Procter & Gamble Company Two-phase dispensing systems utilizing bellows pumps
US5638995A (en) * 1994-10-11 1997-06-17 Mazda; Masayosi Bellows container
US5509906A (en) * 1995-05-02 1996-04-23 Healthstar Pharmaceutical Services, Inc. Plungerless syringe
US6332876B1 (en) * 1997-09-08 2001-12-25 Richard Q. Poynter Compressible syringe
USD417000S (en) * 1998-05-07 1999-11-23 Vital Signs Inc. Compressible syringe
USD419672S (en) * 1998-05-08 2000-01-25 Vital Signs Inc. Plungerless syringe
US6540106B2 (en) * 2001-05-21 2003-04-01 Norman G. Gerstner Finger attachable spray device
GB2461886A (en) * 2008-07-16 2010-01-20 Donald Charles Davey A palm held hypodermic device
US10576209B2 (en) 2009-08-21 2020-03-03 Becton Dickinson France Syringe assembly having a flexible or slidable flange
US20110046559A1 (en) * 2009-08-21 2011-02-24 Becton Dickinson France S.A.S. Syringe Assembly Having a Flexible or Slidable Flange
US10112014B2 (en) 2009-08-21 2018-10-30 Becton Dickinson France Syringe assembly having a flexible or a slidable flange
US20110094909A1 (en) * 2009-10-26 2011-04-28 Asp Plastics Pty Limited Sharps container
US8851281B2 (en) * 2009-10-26 2014-10-07 Asp Rights Management Pty Ltd Sharps container
US10835680B2 (en) 2010-10-25 2020-11-17 Bayer Healthcare Llc Bladder syringe fluid delivery system
US9498570B2 (en) 2010-10-25 2016-11-22 Bayer Healthcare Llc Bladder syringe fluid delivery system
US10046106B2 (en) 2010-10-25 2018-08-14 Bayer Healthcare Llc Bladder syringe fluid delivery system
US9180252B2 (en) 2012-04-20 2015-11-10 Bayer Medical Care Inc. Bellows syringe fluid delivery system
US10105491B2 (en) 2012-04-20 2018-10-23 Bayer Healthcare Llc Collapsible syringe for fluid delivery system
US20170007500A1 (en) * 2014-02-12 2017-01-12 Sanofi-Aventis Deutschland Gmbh Reservoir for liquid medicament
US10874588B2 (en) * 2014-02-12 2020-12-29 Sanofi-Aventis Deutschland Gmbh Reservoir for liquid medicament
CN105979923A (en) * 2014-02-12 2016-09-28 赛诺菲-安万特德国有限公司 Reservoir for liquid medicament
WO2015153469A1 (en) 2014-03-31 2015-10-08 Amcor Limited Controlled release container
EP3125852A4 (en) * 2014-03-31 2017-12-13 Amcor Limited Controlled release container
US10543121B2 (en) 2014-03-31 2020-01-28 Amcor Rigid Plastics Usa, Llc Controlled release container
US11717614B2 (en) 2014-04-25 2023-08-08 Bayer Healthcare Llc Syringe with rolling diaphragm
US10583256B2 (en) 2014-04-25 2020-03-10 Bayer Healthcare Llc Syringe with rolling diaphragm
US20170197031A1 (en) * 2014-06-04 2017-07-13 Merck Sharp & Dohme Corp. Prefilled disposable injection device
US10543317B2 (en) * 2014-06-04 2020-01-28 Merck Sharp & Dohme Corp. Prefilled disposable injection device
US10933190B2 (en) 2015-04-24 2021-03-02 Bayer Healthcare Llc Syringe with rolling diaphragm
US11154665B2 (en) 2015-06-24 2021-10-26 Ethicon, Inc. Hemostatic powder delivery devices and methods
US11717619B2 (en) 2015-06-24 2023-08-08 Ethicon, Inc. Hemostatic powder delivery devices and methods
US11123499B2 (en) 2016-01-19 2021-09-21 Merck Sharp & Dohme Corp. Prefilled disposable injection device
US11878158B2 (en) 2016-01-19 2024-01-23 Merck Sharp & Dohme Llc Prefilled disposable injection device
US11389585B2 (en) 2016-09-16 2022-07-19 Bayer Healthcare Llc Pressure jacket having syringe retaining element
US11547793B2 (en) 2016-10-17 2023-01-10 Bayer Healthcare Llc Fluid injector with syringe engagement mechanism
US11207462B2 (en) 2016-10-17 2021-12-28 Bayer Healthcare Llc Fluid injector with syringe engagement mechanism
USD879952S1 (en) * 2017-08-10 2020-03-31 Ethicon Llc Powder delivery device
US11826541B2 (en) 2017-09-13 2023-11-28 Bayer Healthcare Llc Sliding syringe cap for separate filling and delivery
US11918775B2 (en) 2019-09-10 2024-03-05 Bayer Healthcare Llc Pressure jackets and syringe retention features for angiography fluid injectors
US11938093B2 (en) 2020-02-21 2024-03-26 Bayer Healthcare Llc Fluid path connectors for medical fluid delivery
US11839751B2 (en) 2020-06-18 2023-12-12 Bayer Healthcare Llc In-line air bubble suspension apparatus for angiography injector fluid paths

Also Published As

Publication number Publication date
GB1175184A (en) 1969-12-23
FR1513706A (en) 1968-02-16
DE1566635A1 (en) 1969-11-06

Similar Documents

Publication Publication Date Title
US3473524A (en) Syringe ampoules
US3340869A (en) Collapsible ampoules
US2408323A (en) Hypodermic syringe
US2699167A (en) Hypodermic injector
US2880725A (en) Syringe assembly
US2950717A (en) Ampules
US3669111A (en) Automatic retracting hypodermic syringe
US3478937A (en) Disposable single unit-dose syringe with locking plunger
US3527215A (en) Syringe construction having internal bladder
EP0635278B1 (en) - Self-aspirating syringe or cartridge having an aspirating plunger
US4373526A (en) Device for injection syringe
US3766918A (en) Self-aspirating hypodermic ampule
US3387609A (en) Closure cap for disposable hypodermic syringes
PT1284764E (en) Medical device
US4381779A (en) Deformable slidable piston to provide self-aspiration in hypodermic cartridge ampoules
US2625157A (en) Single dosage disposable hypodermic syringe ampoule and assembly
US2922419A (en) Hypodermic syringe assembly
US3118448A (en) Hypodermic assembly
US2855932A (en) Artificial insemination and cervical medication means
US3089489A (en) Aspirating type hypodermic syringes
US3380449A (en) Cartridge with burstable seal
US3308821A (en) Disposable hypodermic syringes
US2453591A (en) Hypodermic syringe
US3215142A (en) Bulb-type syringe
US3373743A (en) Disposable hypodermic syringe